Limited Comparative Evidence Between Metabolic Bariatric Surgery and Incretin-Based Pharmacotherapy for Weight Loss in Type 2 Diabetes: A Systematic Review and Meta-Analysis.

Baniowdeh O, Arar A, Muslih Y, Obeidat T, Marji E, Elghandour S, Jbara J, Shengelia L

Open source

DOI
10.1111/1753-0407.70259
Published
2026 Aug
Container
Journal of diabetes
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/1753-0407.70259,
  title = {Limited Comparative Evidence Between Metabolic Bariatric Surgery and Incretin-Based Pharmacotherapy for Weight Loss in Type 2 Diabetes: A Systematic Review and Meta-Analysis.},
  author = {Baniowdeh O and Arar A and Muslih Y and Obeidat T and Marji E and Elghandour S and Jbara J and Shengelia L},
  year = {2026},
  journal = {Journal of diabetes},
  doi = {10.1111/1753-0407.70259},
  url = {https://doi.org/10.1111/1753-0407.70259}
}

RIS

TY  - JOUR
TI  - Limited Comparative Evidence Between Metabolic Bariatric Surgery and Incretin-Based Pharmacotherapy for Weight Loss in Type 2 Diabetes: A Systematic Review and Meta-Analysis.
AU  - Baniowdeh O
AU  - Arar A
AU  - Muslih Y
AU  - Obeidat T
AU  - Marji E
AU  - Elghandour S
AU  - Jbara J
AU  - Shengelia L
PY  - 2026
JO  - Journal of diabetes
DO  - 10.1111/1753-0407.70259
UR  - https://doi.org/10.1111/1753-0407.70259
ER  - 

APA

O, B., A, A., Y, M., T, O., E, M., S, E., J, J., & L, S. (2026). Limited Comparative Evidence Between Metabolic Bariatric Surgery and Incretin-Based Pharmacotherapy for Weight Loss in Type 2 Diabetes: A Systematic Review and Meta-Analysis.. Journal of diabetes. https://doi.org/10.1111/1753-0407.70259

Source records